Drugmakers may soon face renewed pressure on high prices, now that Republicans have pulled their American Health Care Act, Citi says.
The value investor discusses his favorite plays for the rest of the bull market in an interview with CNBC's Kelly Evans.
Asset prices are elevated everywhere, Oaktree Capital's Howard Marks says. Here's how he's investing.
Earnings are out for Express Scripts. CNBC's Meg Tirrell reports the details.
U.S. stock index futures pointed to a lower to flat open on Tuesday as traders eyed earnings, data and comments from Janet Yellen.
Jim Cramer says this one word is now the kiss of death on a conference call.
Jim Cramer goes through his lightning round of callers, and weighs in on the state of oil ahead of the rig count.
Express Scripts said despite the double-digit increase, costs for employers rose just 2.5 percent across all prescription drugs.
The leader of the biggest U.S. benefits manager believes an Obamacare replacement can be crafted to save money for the nation and for Americans.
Tim Wentworth, Express Scripts CEO, says the company has invested heavily in digital tools to help members access the lowest price drugs.
Tim Wentworth, Express Scripts CEO, talks to CNBC's Meg Tirrell, about ways to drive down the low-term cost of drugs.
Citron Research says Express Scripts is the "Gotti of Pharma."
CNBC's Jim Cramer gives insight to investors about whether they should jump into the market or wait now that the Dow has passed the 20,000 milestone.
Mylan CEO Heather Bresch speaks to CNBC's Meg Tirrell about the future of EpiPen pricing under President-elect Donald Trump as he pushes to bring drug prices down.
Mylan CEO Heather Bresch speaks to CNBC's Meg Tirrell about the future of EpiPen pricing.
CNBC's Meg Tirrell speaks with Express Scripts President & CEO Tim Wentworth on pharmacy benefit managers and drug pricing pressure.
Pharmaceutical industry’s middlemen face a greater scrutiny next year, according to Breakingviews.
This is a stock picker's market, says Bob Doll, Nuveen Asset Management, providing his top stock plays. I love the airlines, says Doll.
CNBC's Meg Tirrell reports on the launch of Mylan's "authorized generic" version of their EpiPen.
Some of the names on the move ahead of the open.